Key result
RAG2 interacts with RAG1 to disrupt RAG1 aggregates and activate robust V(D)J recombination, demonstrating a species-specific regulatory mechanism.
RAG2 coevolves with RAG1 to release inert RAG1 from aggregates, thereby activating V(D)J recombination to generate diverse antigen receptors.
Answers are grounded in this paper and cite their sources.
RAG2 disrupts RAG1 aggregates to enable V(D)J recombination; leaves open its relevance to immune dysregulation in cardiovascular disease.
RAG1 and RAG2 form a tetramer nuclease to initiate V(D)J recombination in developing T and B lymphocytes. The RAG1 protein evolves from a transposon ancestor and possesses nuclease activity that requires interaction with RAG2. Here, we show that the human RAG1 aggregates in the nucleus in the absence of RAG2, exhibiting an extremely low V(D)J recombination activity. In contrast, RAG2 does not aggregate by itself, but it interacts with RAG1 to disrupt RAG1 aggregates and thereby activate robust V(D)J recombination. Moreover, RAG2 from mouse and zebrafish could not disrupt the aggregation of human RAG1 as efficiently as human RAG2 did, indicating a species-specific regulatory mechanism for RAG1 by RAG2. Therefore, we propose that RAG2 coevolves with RAG1 to release inert RAG1 from aggregates and thereby activate V(D)J recombination to generate diverse antigen receptors in lymphocytes.
No takes yet. Share an insight, caveat, or question.
Gan et al. (2021) studied this question. RAG2 vs. Absence of RAG2 was evaluated on V(D)J recombination activity and RAG1 aggregation. RAG2 interacts with RAG1 to disrupt RAG1 aggregates and activate robust V(D)J recombination, demonstrating a species-specific regulatory mechanism.
Synapse has enriched 10 related papers. Consider them for comparative context: